Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Issue title: Papers from the Regensburg Conference, Regensburg, Germany, 5–6 September 2008
Article type: Research Article
Authors: Franke, R.P.; | Fuhrmann, R. | Hiebl, B. | Jung, F.;
Affiliations: Zentralinstitut für Biomedizinische Technik, Abteilung Biomaterialien, Universität Ulm, Ulm, Germany | GKSS-Forschungszentrum Geesthacht, Berlin–Brandenburg Center for Regenerative Therapies, Campus Virchow-Klinikum der Charité, Universitätsmedizin Berlin, Berlin, Germany
Note: [] Corresponding author: Prof. Dr. F. Jung, Centre for Biomaterial Development, Kantstr. 55, 14513 Teltow, Germany. Tel.: +49 3328 352 269; E-mail: [email protected].
Abstract: Besides the desirable effect of roentgen ray absorption radiographic contrast media (RCM) can also have varying adverse effects. Under discussion, as a possible cause, are microcirculatory disorders resulting from morphological alterations in erythrocytes and endothelial cells. Therefore, the contrast media-induced release of vasoactive substances (prostacyclin, endothelin-1, and nitric oxide (NO)) from human endothelial cells (HUVEC) induced by two commercially available RCMs (Iodixanol 320, Iomeprol 350) was tested in a controlled in-vitro study. The results show that RCMs lead to endothelial cell trauma in vitro, which is apparent in the release of prostacyclin and endothelin-1, while NO release was not affected. The endothelin-1 release after incubation with Iodixanol was similar to the release in the control cultures. In comparison, lower endothelin-1 levels were measured in the cultures incubated with Iomeprol at all 3 time points indicating a more significant cell trauma. Prostacyclin release – also an indicator of traumatization of endothelial cells – increased after addition of both contrast agents. The highest release was found after incubation with Iomeprol 350.
Keywords: Endothelin, prostacyclin, NO, radiographic contrast media, primary human endothelial cells
DOI: 10.3233/CH-2009-1233
Journal: Clinical Hemorheology and Microcirculation, vol. 43, no. 1-2, pp. 181-187, 2009
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]